NUCLEAR DIAGNOSTIC PRODUCTS, INC

Nuclear Diagnostic Products, Inc. specializes in the manufacturing and supply of radiopharmaceuticals for clinical diagnostic applications, with deep expertise in GMP-compliant production, radionuclide formulation, and just-in-time distribution of short-lived isotopes. The company delivers critical nuclear medicine products—including Ga-68 DOTATATE (NetSpot) and other PET radiotracers—under strict regulatory frameworks to support nuclear imaging protocols in oncology, neurology, and cardiology. Their technical capabilities encompass aseptic processing, radiolabeling, quality control testing, and cold kit reconstitution, ensuring compliance with USP <825> and FDA cGMP standards for radiopharmaceuticals. A key differentiator is their ability to maintain reliable, high-frequency supply chains for time-sensitive agents, enabling seamless integration into VA medical center workflows. The contractor maintains an exclusive, long-standing relationship with the Department of Veterans Affairs, consistently providing radiopharmaceuticals across multiple Veterans Integrated Service Networks, including VISN 2 Downstate. Their work supports VA’s nuclear medicine departments in delivering diagnostic imaging services to veterans, with recurring contracts for both routine and bridge supply needs, indicating a trusted, operational partnership built on reliability and regulatory adherence. The company’s primary focus is in NAICS 325412—Pharmaceutical Preparation Manufacturing—specifically within the radiopharmaceutical subsector. They operate at the intersection of nuclear science and clinical healthcare, serving a highly regulated niche where precision, sterility, and temporal logistics are non-negotiable. Their market positioning is that of a specialized supplier to federal medical systems requiring uninterrupted access to diagnostic radiopharmaceuticals. Nuclear Diagnostic Products, Inc. is a small business entity headquartered in Rockaway, New Jersey, with no public certifications on record. Their geographic presence is focused on supporting federal healthcare infrastructure, particularly within the VA network, positioning them as a mission-critical vendor in the national radiopharmaceutical supply chain.